⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FULC News
Fulcrum Therapeutics, Inc. Common Stock
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
globenewswire.com
FULC
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
globenewswire.com
FULC
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
globenewswire.com
FULC
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FULC